DAY 4 - Tuesday, April 24
INNOVATORS’ SESSION
Femtosecond laser non-invasive RIS next for presbyopia
Chicago—The latest innovation in the quest for presbyopic correction may be high-repetition rate femtosecond laser non-invasive refractive index shaping (RIS). Scott MacRae, MD, reviewed the experimental results of this procedure during the Innovators’ Session. » MORE
Addressing presbyopia pharmacologically
Chicago—Monocular treatment of the non-dominant eye by instillation of pilocarpine or carbachol, both cholinergic agonists, and bromonidine (Alphagan-P, Allergan), an alpha agonist that can prolong the effect of cholinergic agonists, might be a new approach to treating presbyopia. Steve Kaufman, MD, PhD, described this potential treatment during the Innovators’ Session. » MORE
REFRACTIVE
Long-term outcome data positive for pediatric LASIK
Chicago—Results from 10 years of follow-up support consideration of LASIK in select children with severe myopic anisometropia where conventional treatment methods have failed, said Claire Hartnett, MD. » MORE
Advanced wavefront-guided results excellent
Chicago—Results from the first clinical trial of myopic LASIK with a new advanced wavefront-guided system are excellent and indicate the procedure is an acceptable and efficacious alternative to conventional LASIK, said W. Bruce Jackson, MD. » MORE
Meeting patient needs with contact lenses
Chicago—Incorporating contact lens fitting into refractive surgical practices is critical to achieve successful visual outcomes. According to Warren Fagadau, MD, this is an area that has been relatively neglected in ophthalmology. » MORE
CORNEA
Products expand contact lens options for keratoconus
Chicago—New contact lenses are available for patients with keratoconus and should be considered to reduce the number of patients who progress along the treatment algorithm to require surgical intervention, said Brandon Ayres, MD. » MORE
DALK preferred over PK
Chicago—Deep anterior lamellar keratoplasty (DALK) is the procedure of choice for treating patients with keratoconus and corneal scarring, according to Deepinder Dhaliwal, MD. » MORE
GLAUCOMA
Positive outcomes support two trabecular bypass stents
Chicago—Interim results from a prospective study support the safety and efficacy of micro-invasive glaucoma surgery with implantation of two trabecular bypass stents (iStent, Glaukos) for reducing IOP and medication burden in phakic and pseudophakic eyes with mild-to-moderate open-angle glaucoma uncontrolled on one ocular hypotensive medication, said David F. Chang, MD. » MORE
FROM THE SHOW FLOOR
Alcon debuts WaveLight EX500 excimer laser
Chicago—Alcon Laboratories introduced its latest innovation in LASIK surgery technology, the WaveLight EX500 excimer laser, during the 2012 meeting of the American Society of Cataract and Refractive Surgery. » MORE
Carl Zeiss Meditec to initiate trial of ReLEx method
Chicago—Carl Zeiss Meditec announced its intention to initiate a U.S. clinical trial of the ReLEx smile procedure for the correction of myopia, having received conditional approval for the trial from the FDA. » MORE
DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times. The sponsor does not endorse and is not responsible for the accuracy of the content or for practices or standards of non-sponsor sources.
|
